Alexion Jumps After Blood Disorder Drug Succeeds In Head-To-Head Trial
March 15, 2018 at 09:36 AM EDT
Shares of Alexion jumped in pre-market trading after the company said its rare blood disorder drug was successful in a late-stage study.